News & Events

 

EAP Logo

The Office of Chief Health and Medical Officer and the Office of the Chief of Human Capital Management Officer coordinated an adobe connect webinar session with the American Foundation for Suicide Prevention (AFSP)https://afsp.org/about-suicide/

 Date: September 26:  1:00 – 2:00 pm Eastern

 Speaker:  Dr. Christine Moutier, Chief Medical Officer, American Foundation for Suicide Prevention (AFSP)

 Topic: This presentation will provide a discussion on suicide evidence-based research, suicide prevention methods, warning signs, risk factors and current treatment options.

 Adobe Connect Link:          https://itcdhqnasa.acms.com/afsp/

The OH Webpage https://inside.nasa.gov/health4life will also have the adobe connect link.

 


This HR Message is being delivered to you via HRMES On Behalf Of: Agency Drug Testing Program Manager


 

Cannabidiol (CBD) oil, which is a chemical compound extracted from the flowers and buds of the hemp (cannabis sativa) plant, has increased in popularity as a result of the claims that it is a natural remedy for common ailments such as chronic pain and anxiety. There are no standards governing the manufacturing of products containing CBDs; however, products that contain pure CBDs typically has less than 0.3% of the Tetrahydrocannabinol (THC), the psychoactive compound of the cannabis plant associated with the sensation of feeling “high.” The lack of standards means there are CBD products being marketed that contains a sufficient level of THC to cause a positive drug test result. Please be aware that, the use of any compounds or substances not approved by the FDA cannot be used as a legitimate medical explanation for a positive drug test result.

As a reminder, the use of illegal drugs by federal employees is not permissible under any circumstances, regardless of state and/or local laws; this includes the use of Marijuana or products that contains THC for recreational and/or medical purposes.

NASA is authorized to conduct pre-employment testing of any individual who will occupy a testing designated position (TDP) and Random testing of employees who occupy a TDP. All employees are subject to testing under provisions for reasonable suspicion and post-accident and/or unsafe practice testing regardless of the TDP designation of their position.

For more information about NASA’s Drug-Free Workplace Program, please see the NSSC Drug Testing page at https://www.nssc.nasa.gov/drugtesting.

 

 


Potential Articles of Interest

 

April 18, 2019 - NASA Moves
Get ready to step it up in a virtual race from one center to another all across America. A fun fitness challenge that is open to NASA Civil Service Personnel and Contractors. Click here for more details.

April 18, 2019 - American Screenings Onsite
American Screening Association will be at NASA Wallops in the Rocket Club on Wednesday, April 24, 2019. Screenings are available individually or as a package and are eligible for flexible spending accounts and health savings accounts. Appointments are required. Click here for more details.

May 8, 2018 - Wellness Tips - Skin Cancer
Warm weather is approaching. Be sure to protect your skin from harmful UV rays. Read More

April 25, 2018 - Wellness Tips - Eye Safety
Each day, about 2000 U.S. workers have a job-related eye injury that requires medical treatment. Be sure to protect your eyes appropriately against on-the-job hazards. Read More

March 19, 2018 - Wellness Tips - Breakfast
Do you skip breakfast regularly? If so, you may be missing out on some big health benefits. Read More